πŸ‡ΊπŸ‡Έ FDA
Patent

US 7550590

Dipeptidyl peptidase inhibitors

granted A61PA61P15/08A61P15/10

Quick answer

US patent 7550590 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P15/08, A61P15/10, A61P17/00, A61P19/10